Quantitative and Standardized Pseudovirus Neutralization Assay for COVID-19
Authors:
- 26 March 2024
- book chapter
- Published by Springer Nature
- Vol. 2779, 259-271
Abstract
COVID-19 is a global pandemic caused by the highly infectious SARS-CoV-2 virus. Efforts to combat SARS-CoV-2 infection include mass vaccination and development of monoclonal and convalescent plasma therapeutics that require precise measurements of correlative, functional neutralizing antibodies that prevent virus infection. Developing rapid, safe, easy-to-use, and high-quality neutralization assays are essential for the success of the massive effort. Here, we developed a vesicular stomatitis virus-based neutralization assay that was capable of quantifying varying degrees of neutralization in patient serum samples. This assay has two detection readouts, flow cytometry and live cell imaging. The two readout methods produced consistent values of all 50% neutralization titers, further enhancing measurement confidence on the assay. Moreover, the use of available reference standards such as the World Health Organization International Standard (NIBSC code 20/136) enables quantification and standardization of the pseudovirus neutralization assay with neutralizing antibody titers measured in International Units/mL. Quantitative and standardized neutralization assays are critical for reliable efficacy evaluation and comparison of numerous vaccines and therapeutics. Key words Pseudovirus neutralization assay SARS-CoV-2 Neutralizing antibodies VSV-ΔG spike pseudovirus HEK293-hACE2-TMPRSS2-mCherry cell line Multiplicity of infection (MOI) Flow cytometry Live cell imaging WHO International Standard NIBSC 20/136 (WHO IS 20/136) Quantification Assay standardizationKeywords
This publication has 20 references indexed in Scilit:
- A Covid-19 Milestone Attained — A Correlate of Protection for VaccinesNew England Journal of Medicine, 2022
- Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccinesNature Medicine, 2022
- Evidence for antibody as a protective correlate for COVID-19 vaccinesVaccine, 2021
- Advances in Neutralization Assays for SARS‐CoV‐2Scandinavian Journal of Immunology, 2021
- Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survivalNature Communications, 2021
- Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2Cell, 2020
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike GlycoproteinCell, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- An automated fitting procedure and software for dose-response curves with multiphasic featuresScientific Reports, 2015
- Empirical gradient threshold technique for automated segmentation across image modalities and cell linesJournal of Microscopy, 2015